Dr. MERIC SENGOZ
Snapshot Highlights
- Associate Professor at Marmara University Faculty of Medicine
- Expert in Radiation Oncology
- Extensive experience in oncology treatment centers
- Published author in leading medical journals
- Member of prestigious international oncology societies
Professional Journey
Dr. Meric Sengoz has dedicated his career to advancing the field of Radiation Oncology. He holds an Associate Professor title from Marmara University Faculty of Medicine, a testament to his significant contributions and academic standing in the medical community.
Education and Training
- Istanbul University, Faculty of Medicine: Medical Doctorate
- Istanbul University, Cerrahpaşa Medical Faculty: Specialization in Radiation Oncology
- Marmara University, Faculty of Medicine: Associate Professorship
Experience and Affiliations
Dr. Sengoz brings over two decades of experience in Radiation Oncology. His career began with a vital role at the Turkish Cancer Foundation Oncology Center from 1991 to 1996. Subsequently, he served the Department of Radiation Oncology at Marmara University Faculty of Medicine for nearly a decade (1996-2005). Since 2005, Dr. Sengoz has been an integral part of the Acıbadem Health Group, contributing his expertise to patient care and oncology advancements.
Professional Memberships and Engagement
Dr. Sengoz is an active and respected member of numerous national and international medical organizations, underscoring his commitment to collaborative research and the highest standards of medical practice. His affiliations include:
- Turkish Medical Association
- Turkish Radiation Oncology Association
- Turkish Oncology Group
- European Society for Therapeutic Radiation Oncology (ESTRO)
- American Society for Therapeutic Radiation Oncology (ASTRO)
- European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy Group
Research and Publications
Dr. Sengoz has a robust publication record, contributing significantly to the body of knowledge in Radiation Oncology. His research spans various critical areas of cancer treatment, including chemoradiotherapy efficacy, gamma-knife surgery outcomes, and the management of rare cancers. Key publications include studies on nasopharyngeal carcinoma, meningiomas, rectal cancer, solitary plasmacytoma, and the protective effects of melatonin against radiation-induced damage. He has also authored research on the technical aspects of radiation therapy delivery and concurrent chemoradiotherapy for lung cancer. His work has been featured in esteemed journals such as J BUON, Zentralbl Neurochir, and BMC Cancer.